Stay updated on SPI-2012 in Breast Cancer Neutropenia Clinical Trial
Sign up to get notified when there's something new on the SPI-2012 in Breast Cancer Neutropenia Clinical Trial page.

Latest updates to the SPI-2012 in Breast Cancer Neutropenia Clinical Trial page
- Check5 days agoChange DetectedThe ClinicalTrials.gov record for a Phase 2 breast cancer study comparing SPI-2012 with pegfilgrastim is displayed, including study design, eligibility criteria, participating locations, and outcome measures. The record also includes its publication and study history.SummaryDifference81%

- Check13 days agoChange DetectedThe footer revision label changed from v3.7.2 to v3.8.0; the page remains a 403 Forbidden error.SummaryDifference0.2%

- Check19 days agoChange DetectedA site-wide notice announces that NIH is transitioning from the term “Artificial Intelligence” to “Super Intelligence” and links to updates and FAQs.SummaryDifference1%

- Check26 days agoChange DetectedThe footer revision label changed from v3.7.1 to v3.7.2 on the 403 error page.SummaryDifference0.2%

- Check33 days agoChange DetectedThe footer revision label changed from v3.7.0 to v3.7.1 while the page continued to display a 403 Forbidden error.SummaryDifference0.2%

- Check54 days agoChange DetectedThe study page now shows a 403 Forbidden error, replacing the detailed study content and making the record inaccessible; the page currently displays a basic header with a Home link and a revision notice.SummaryDifference21%

Stay in the know with updates to SPI-2012 in Breast Cancer Neutropenia Clinical Trial
Enter your email address, and we'll notify you when there's something new on the SPI-2012 in Breast Cancer Neutropenia Clinical Trial page.